@article{d9c6321494f74d18bfbee08c6caaa49f,
title = "Update on Cardiac Catheterization in Patients With Prior Coronary Artery Bypass Graft Surgery",
abstract = "Patients who undergo coronary bypass graft surgery often require subsequent cardiac catheterization and repeat coronary revascularization. Saphenous vein graft lesions have high rates for distal embolization that can be reduced with use of embolic protection devices. They also have high restenosis rates, which are similar with drug-eluting and bare-metal stents. Percutaneous coronary interventions of native coronary arteries is generally preferred over saphenous vein graft interventions, but can often be complex, requiring expertise and specialized equipment. Prolonged dual-antiplatelet therapy and close monitoring can help optimize subsequent clinical outcomes.",
keywords = "coronary artery bypass grafting surgery, percutaneous coronary intervention, revascularization",
author = "Iosif Xenogiannis and Peter Tajti and Hall, {Allison B.} and Khaldoon Alaswad and St{\'e}phane Rinfret and William Nicholson and Dimitri Karmpaliotis and Kambis Mashayekhi and Sergey Furkalo and Cavalcante, {Jo{\~a}o L.} and Burke, {M. Nicholas} and Brilakis, {Emmanouil S.}",
note = "Funding Information: Dr. Alaswad has received consulting fees from Terumo and Boston Scientific; and has been an unpaid consultant for Abbott Laboratories. Dr. Rinfret has received speaker and proctorship honoraria from Boston Scientific, Abbott Vascular Canada, Medtronic Canada, SoundBite, and Terumo US. Dr. Nicholson has been a proctor, consultant, and advisory board member for Abbott Vascular, Boston Scientific, and Medtronic. Dr. Karmpaliotis has received speaker honoraria from Abbott Vascular and Boston Scientific. Dr. Mashayekhi has received consulting/speaker fees from Ashai Intecc, AstraZeneca, Biotronik, Boston Scientific, Cardinal Health, Daiichi-Sankyo, Medtronic, Teleflex, and Terumo. Dr. Cavalcante has received research grants from Medtronic and Abbott; and has been a consultant/speaker for Medtronic, Circle Cardiovascular Imaging, and Siemens Inc. Dr. Burke has received consulting and speaker honoraria from Abbott Vascular and Boston Scientific. Dr. Brilakis has received consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor: Circulation), Boston Scientific, Cardiovascular Innovations Foundation (board of directors), CSI, Elsevier, GE Healthcare, InfraRedx, and Medtronic; has received research support from Regeneron and Siemens; is a shareholder in MHI Ventures; and has served on the board of trustees for the Society of Cardiovascular Angiography and Interventions. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Publisher Copyright: {\textcopyright} 2019 American College of Cardiology Foundation",
year = "2019",
month = sep,
day = "9",
doi = "10.1016/j.jcin.2019.04.051",
language = "English (US)",
volume = "12",
pages = "1635--1649",
journal = "JACC: Cardiovascular Interventions",
issn = "1936-8798",
publisher = "Elsevier Inc.",
number = "17",
}